The FDA placed it in 503A Category 2 ("may present significant safety risks") in 2023, effectively barring compounding pharmacies from using it, then removed it from that category in April 2026 after nominators withdrew their submission, without adding it to the approved Category 1 compounding list
If you dont, youll have peace of mind
This wide array of potential applications makes it a compelling subject for continued scientific inquiry
Why Choose Chronos for B12 Shots
Vaccines People may receive vaccine injections to reduce their risk of certain infections
Key Areas of Research: Tissue Repair: Healing and structural cell recovery Vascular Support: Angiogenesis and endothelial repair Inflammatory Regulation: Response modulation and cytokine balance Systemic Studies: Combined multi-pathway recovery response Collectively, these findings indicate the blends value for exploring mechanisms of accelerated recovery, tissue protection, and cellular adaptation under controlled conditions
